TP53 and hepatocellular carcinoma: NEAT1, found to be diminished in hepatitis C and associated HCC, enhanced the diagnostic accuracy of HCC in hepatitis C patients when combined with TUG1, p53, and AFP (Mohyeldeen et al., 2020).